New Research Links Depression to Increased Risk of Multiple Chronic Diseases
March 27, 2025
Mood disorders are increasingly viewed as whole-body conditions aff...
Read More
Rheumatoid Arthritis Linked to Faster Cognitive Decline in Dementia Patient
March 21, 2025
Rheumatoid arthritis (RA) has been linked to an increased risk of d...
Read More
Study Demonstrates Success in Shifting Adolescent Sleep Patterns Through Targeted Interventions
March 12, 2025
A recent study examined whether a motivational group-based sleep in...
Read More
FDA Approves Axsome Therapeutics’ AXS-07 for Migraine Treatment
March 10, 2025
The FDA recently approved. AXS-07 is an oral, rapidly absorbed, mul...
Read More
New Insights into Esketamine Treatment: Efficacy, Safety, and Long-Term Effects
March 4, 2025
Intranasal esketamine has been approved as an adjunctive pharmacoth...
Read More
Deprescribing Antidepressants in Children and Adolescents
March 3, 2025
When considering the discontinuation of antidepressant treatment, f...
Read More
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder
February 24, 2025
A recent randomized clinical trial provides promising evidence that...
Read More
Population Study Reveals Most Effective Antipsychotic Strategies for First-Episode Schizophrenia
February 16, 2025
A recent population-based cohort study examined the effectiveness o...
Read More
Social Determinants of Health and Suicide-Related Outcomes
February 12, 2025
Over 700,000 deaths annually are attributable to suicide. While psy...
Read More
Associations Between Biomarkers of Inflammation and Depressive Symptoms
February 7, 2025
A recent study published in Translational Psychiatry has provided ...
Read More
Depressive Symptoms and Amyloid Pathology
February 1, 2025
A recent large-scale study examined the association between depress...
Read More
Label Update for Viloxazine ER: New Pharmacodynamic Data and Breastfeeding Info
January 27, 2025
The FDA has approved an update for the label for viloxazine ER to n...
Read More